Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IPA-3 |
Trade Name | |
Synonyms | |
Drug Descriptions |
IPA-3 is a selective inhibitor of PAK1, which results in decreased PAK1 signaling, and may result in decreased tumor cell growth(PMID: 18420139, PMID: 23894351, PMID: 3224065). |
DrugClasses | PAK1 Inhibitor 11 |
CAS Registry Number | 42521-82-4 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
EHop-016 + IPA-3 | EHop-016 IPA-3 | 0 | 0 |
Gefitinib + IPA-3 | Gefitinib IPA-3 | 0 | 0 |
IPA-3 | IPA-3 | 0 | 0 |